Recent Updates
Recently added Catalysts
MYO Positive Sentiment

Myomo to Participate in Two Investor Conferences in September

Thursday, September 5, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Myomo, Inc. has announced its participation in two investor conferences in September 2024. The company specializes in wearable medical robotics aimed at enhancing functionality for individuals with neurological disorders and upper-limb paralysis. This engagement reflects Myomo's commitment to connecting with investors and promoting its innovative solutions.
Price reaction · baseline $3.755 (2024-09-05T16:12:00.000Z) · hit during market hours · clean, no other MYO news in the window
day 0 close · peak
+0.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Myomo is actively engaging with investors.
  • Participation in conferences indicates growth potential.
  • Focus on innovative medical robotics for neurological disorders.

Full Press Release Details

BOSTON (September 5, 2024) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will be participating in two investor conferences during the month of September. Read more .

Frequently Asked Questions

What is Myomo's focus area?

Myomo specializes in wearable medical robotics for neurological disorders.

When will Myomo participate in investor conferences?

Myomo will participate in two investor conferences in September 2024.

What does Myomo aim to achieve at these conferences?

Myomo aims to engage with investors and promote its innovative solutions.

ShareAdd on Google
Tags: MYO Viatris Investor Conferences Healthcare Myomo medical robotics investor conferences neurological disorders upper-limb paralysis
Last updated: Sep 5, 2024

Biotech snapshot

Cash runway
$13M liquidity · $1M/mo burn
~20 mo
Low dilution risk